Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Recurrence in the pelvic side wall after lateral lymph node dissection for rectal cancer.
Authors
Misato Takao
Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
Misato Takao , Kazushige Kawai , Maki Takagi , Nozomi Funatsu , Soichiro Natsume , Daisuke Nakano , Tatsuro Yamaguchi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 49)
DOI
10.1200/JCO.2024.42.3_suppl.49
Abstract #
49
Poster Bd #
D12
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prognostic impact of local recurrence and timing of palliative radiotherapy in patients with unresectable recurrent rectal cancer.
First Author: Tomoki Sakakida
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association of pathologic nodal status with minimal residual disease after neoadjuvant treatment and resection of locally advanced rectal cancer.
First Author: Abhineet Uppal
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The optimal extent of lymph node dissection for gastric cancer with para-aortic lymph node metastases.
First Author: Takeyuki Wada
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A phase II study of CAPOXIRI as a neoadjuvant chemotherapy in patients with locally advanced rectal cancer (Colorectal Cancer Treatment Group, MSCSGO).
First Author: Yoshinori Kagawa